RxDoctor Payments Data

Kathleen Fryburger

Physician Assistant · Fredericksburg, TXNPI 1053396077

Payments from drug & device makers

$1,627in general payments, 2019–2025

Across 54 payments — averaging $30.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$352
  • Inspire Medical Systems, Inc.$328
  • Aerin Medical Inc.$217
  • AstraZeneca$144
  • GSK$108
  • Blueprint Medicines Corporation$106
  • plus $372 from 12 others

What the payments were for

  • Food & beverage$1,627100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,627 in reported general payments places this provider in the 70th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$281,824
Medicare patients
792
Services billed
3,816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol27$11,791
Epinephrine42$8,504
Spiriva RespimatTiotropium Bromide13$8,442
Fluticasone Propionate543$8,395
Azelastine Hcl327$8,276
Ipratropium Bromide204$6,148
OdactraMite,d.Farinae-D.Pteronyssinus11$5,313
Montelukast Sodium344$3,888
Cefdinir97$1,906
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav167$1,436
Ofloxacin49$1,419
Pilocarpine Hcl22$1,254
Levocetirizine Dihydrochloride69$1,149
Levothyroxine Sodium91$769
Hydrochlorothiazide109$526

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta$108$11,79127 claims
Hikma Pharmaceuticals USAEpinephrine$17$8,50442 claims
Alk-abello, IncOdactra$84$5,31311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fredericksburg

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →